Back to Results

Terrascend Corp (TSNDF)

TerrAscend Corp. is a common stock listing on OTC Markets for a healthcare company focused on cannabis. Through its operations in Canada and the United States, the company cultivates, produces, and sells cannabis products, including vaporizables, concentrates, topicals, flowers, tinctures, and edibles. Its portfolio includes brands such as Kind Tree Cannabis, Legend, Valhalla Confections, State Flower Cannabis, Ilera Healthcare, Wana, and Cookies. TerrAscend also operates retail dispensaries under the Apothecarium name and serves both medical patients and adult-use consumers across North America. Incorporated in 2017, the company is headquartered in Mississauga, Canada.


Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Market Outlook FAQ

Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Dividend Yield Next Earnings Date Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Free Cash Flow / Net Income
OTC-TSND.F
$0.65
-0.7% Downside
Fair
$1.50
129.3% Upside
Bargain
Good
0.0%
November 5, 2026
3.1x
0.9x
244.6 M
412.5 M
49.7%
71.4%
-5.0
-60.7%
Valuation • Fair Value

Terrascend Corp (OTC-TSND.F) Fair Value by Valuation Model

Review the available estimates for Terrascend Corp (OTC-TSND.F), including EPV Fair Value, Comps Fair Value.

Primary Valuation Read

Fair Value

$0.65

Estimated downside of 0.7% versus the current market price.

Fair Value Confidence

Low

Confidence level for the primary fair value estimate.

EPV Fair Value

$0.34

Earnings power value estimate.

Comps Fair Value

$0.70

Comparable-company valuation reference.

Analyst Price Target

$1.50

Analysts imply upside of 129.3%.

How to read these valuation models

Use the 5 available valuation references for Terrascend Corp (OTC-TSND.F) as analytical inputs, not a standalone conclusion. Valuation methods can differ because they rely on different assumptions, time horizons and financial inputs; compare the estimates with the current price and the company’s financial quality.

Profitability • Growth

Profitability & Growth for Terrascend Corp (OTC-TSND.F)

Review the profitability and growth indicators currently supported by the latest data.

Revenue

263.9 M

Current operating scale indicator.

Revenue Forecast

266.7 M

Forward revenue estimate.

EBITDA

60.833 M

Current operating profitability reference.

EBITDA Forecast

69 M

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review Terrascend Corp (OTC-TSND.F) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Terrascend Corp (OTC-TSND.F)

Review the financial quality and risk indicators currently supported by the latest data.

Financial Health

Good

Positive financial-health read.

Piotroski Score

6

Mid-range quality score.

Beneish M-Score

-3.10

No elevated caution signal from this screen.

Altman Z-Score

-5.0

Lower score that deserves closer risk review.

FCF / Net Income

-60.7%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Terrascend Corp (OTC-TSND.F). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for Terrascend Corp (OTC-TSND.F)

Track the upcoming dates and dividend metrics currently supported by the latest data.

Next Earnings Date

November 5, 2026

Days to Earnings

48

Dividend Yield

0.0%

No current dividend yield is indicated.

How to read events and dividends

This section helps investors track time-sensitive items for Terrascend Corp (OTC-TSND.F), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Stock Forecast • Technical Outlook

Terrascend Corp (OTC-TSND.F) Stock Forecast & Technical Outlook

Review Terrascend Corp (OTC-TSND.F) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Buy

The 15-minute technical read for Terrascend Corp (OTC-TSND.F) is currently Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Strong Buy

The 1-hour technical read for Terrascend Corp (OTC-TSND.F) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Neutral

The daily technical read for Terrascend Corp (OTC-TSND.F) is currently Neutral. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Buy

The weekly technical read for Terrascend Corp (OTC-TSND.F) is currently Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Sell

The monthly technical read for Terrascend Corp (OTC-TSND.F) is currently Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for Terrascend Corp (OTC-TSND.F)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Strong Buy

Based on the available recommendation mix, Terrascend Corp (OTC-TSND.F) has a Strong Buy consensus, with 2 buy, 0 hold and 0 sell recommendations in the current data set.

Buy 2
Hold 0
Sell 0
FAQ • Fast Investor Answers

Terrascend Corp (OTC-TSND.F) Stock FAQ

Data-supported answers about Terrascend Corp (OTC-TSND.F), including explicit coverage status where a reliable valuation estimate is not currently available.

Fair Value
$0.65
Estimated downside 0.7%
Valuation Rating
Near Fair Value
Price is close to fair value
Analyst Target
$1.50
Implied upside 129.3%
Financial Health
Good
Current financial-health read

The current fair value estimate for Terrascend Corp (OTC-TSND.F) is $0.65. This implies an estimated downside of 0.7% versus the current market price.

Based on the current fair value estimate, the stock is trading close to its estimated fair value.

The available analyst price target for Terrascend Corp (OTC-TSND.F) is $1.50. The analyst target implies estimated upside of 129.3%.

The current financial health read for Terrascend Corp (OTC-TSND.F) is Good. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for Terrascend Corp (OTC-TSND.F) is November 5, 2026.

The latest available data indicates no current dividend yield for Terrascend Corp (OTC-TSND.F).

The current market capitalization listed for Terrascend Corp is 244.6 M.

The current enterprise value listed for Terrascend Corp is 412.5 M. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Terrascend Corp is OTC-TSND.F, and the stock is listed on OTC Markets.

Terrascend Corp (OTC-TSND.F) is listed on OTC Markets.

The current debt-to-total-capital ratio listed for Terrascend Corp is 49.7%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Terrascend Corp is 71.4%. Free float helps investors understand how much of the share base is available for public trading.

Similar Pharmaceuticals Stocks View more on OTC Markets

Comparable companies from the same industry, limited to one security per issuer.

LLY NYSE Eli Lilly and Company Fair Value Fair Market Cap 1,027.7 B
JNJ NYSE Johnson & Johnson Fair Value Fair Market Cap 650.6 B
MRK NYSE Merck & Company Inc Fair Value Fair Market Cap 362.4 B
NVS NYSE Novartis AG ADR Fair Value Fair Market Cap 266.2 B
NVO NYSE Novo Nordisk A/S Fair Value Bargain Market Cap 191.3 B
PFE NYSE Pfizer Inc Fair Value Fair Market Cap 157.7 B
BMY NYSE Bristol-Myers Squibb Company Fair Value Fair Market Cap 128.8 B
SNY NASDAQ Sanofi ADR Fair Value Undervalued Market Cap 101.9 B
GSK NYSE GSK plc DRC Fair Value Undervalued Market Cap 100.8 B
TAK NYSE Takeda Pharmaceutical Co Ltd ADR Fair Value Fair Market Cap 60.801 B
TEVA NYSE Teva Pharma Industries Ltd ADR Fair Value Fair Market Cap 45.423 B
HLN NYSE HALEON PLC ADR Fair Value Fair Market Cap 40.198 B
RPRX NASDAQ Royalty Pharma Plc Fair Value Fair Market Cap 33.653 B
ZTS NYSE Zoetis Inc Fair Value Bargain Market Cap 29.504 B
VTRS NASDAQ Viatris Inc Fair Value Undervalued Market Cap 19.446 B
JAZZ NASDAQ Jazz Pharmaceuticals PLC Fair Value Fair Market Cap 15.628 B
CORT NASDAQ Corcept Therapeutics Incorporated Fair Value Fair Market Cap 11.943 B
ELAN NYSE Elanco Animal Health Fair Value Fair Market Cap 11.202 B
AXSM NASDAQ Axsome Therapeutics Inc Fair Value Fair Market Cap 10.884 B
RDY NYSE Dr. Reddy’s Laboratories Ltd ADR Fair Value Fair Market Cap 10.161 B